摘要
Hae Jin LEE 医师
皮肤科医师
Revisiting hair loss therapy: my clinical experience with the latest skin boosters
Objectives: This presentation aims to share clinical experiences and evaluate the efficacy of integrating various skin boosters and biostimulators into conventional androgenetic alopecia (AGA) treatment protocols to improve the scalp environment and maximize treatment response rates.
Introduction: While conventional treatments for androgenetic alopecia (AGA), such as 5-alpha reductase inhibitors and minoxidil, remain the gold standard, varying clinical response rates highlight the need for adjunctive therapies. Recently, the importance of the scalp microenvironment in hair follicle has been emphasized. The advent of novel skin boosters and biostimulators offers a promising strategy to rejuvenate the scalp, thereby potentially enhancing the efficacy of standard hair loss treatments.
Materials / method: The treatment regimen included local injections of the latest biostimulators and skin boosters (e.g., Poly-D,L-Lactic Acid (PLA), atelocollagen, and non-crosslinked hyaluronic acid), as well as platelet-rich plasma(PRP). The presentation will detail the specific protocols, injection depths, intervals, and customized approaches based on individual scalp conditions.
Results: Clinical observations demonstrated that the combination of standard AGA therapy with biostimulators resulted in a more rapid and robust improvement in hair density and shaft thickness compared to conventional monotherapy. Furthermore, patients exhibited significant enhancements in overall scalp microenvironment. The adjunctive use of these boosters yielded higher patient satisfaction and adherence, with no significant adverse events reported.
Conclusion: Optimizing the scalp microenvironment is a crucial factor in successful hair loss management. The strategic incorporation of the latest skin boosters and biostimulators serves as a highly effective adjunctive approach, significantly boosting the clinical response rates of traditional AGA therapies.
披露 - Hae Jin LEE
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2026年 7月 30日 - Recorded during IMCAS Asia 2026